Answers are grounded in this paper and cite their sources.
Optogenetic stimulation enhances glioma growth in pons and neocortex, indicating cholinergic neurons are critical mediators.
Neuronal activity robustly drives the progression of diffuse midline gliomas (DMG), mediated through paracrine and synaptic neuron-to-glioma interactions. To date, research has primarily focused on glutamatergic and GABAergic neurons, while the impact of neuromodulatory neuron subpopulations and their long-range projections remain largely unexplored. Here, we explore the glioma-promoting effects of serotonergic and cholinergic brainstem neurons. By employing optogenetic stimulation of midbrain serotonergic or cholinergic neurons in mice-bearing DMG allografts or xenografts, we observed circuit-specific effects of each neuromodulatory neuronal subtype on proliferation. We found that serotonergic neurons of the DRN promoted DMG proliferation in the neocortex and pons, while those from the MRN increased cell proliferation in the thalamus. Similarly, stimulation of cholinergic neurons in the LDT enhanced thalamic glioma growth, and stimulation of the PPN promoted pontine tumor growth. A bidirectional signalling effect was evident, as baseline neuronal activity in both neuronal subpopulations within all nuclei was elevated in DMG-bearing mice compared to control-injected animals. The long-range activity-regulated effects on glioma cells were mediated by neurotransmitter secretion at axon terminals, as well as paracrine signalling protein release locally in the brainstem. The activity-regulated paracrine factor profiles promoting DMG proliferation are distinct between serotonergic and cholinergic neurons, illustrating neuron subtype-specific pathophysiological mechanisms affecting glioma cells beyond neurotransmitter differences. Co-culture of hESC-derived cholinergic or serotonergic neurons with DMG cells demonstrated synaptic structures between both neuromodulatory neuron types and glioma cells, indicating a synaptic component to these neuron-glioma interactions. Integration of scRNA-seq data revealed distinct receptor abundances in DMGs that correlate with specific cellular states. Inhibition of these target receptors – such as M1 or M3 cholinergic receptors– mitigated the proliferation-inducing effects of the relevant neuron subtype on DMG cells. In summary, these findings introduce brainstem cholinergic and serotonergic neuromodulatory neurons as drivers of DMG growth in a circuit-specific manner, adding to the complexity with which gliomas integrate into brain-wide neural circuitry and highlighting new potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Drexler et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: